Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Making sense of drug use and dependence-A scoping review of mass media interventions intended to reduce stigma towards people who use drugs.
Holland A, Freeman TP, Nicholls J, Burke C, Howkins J, Harris M, Hickman M, Attwood A, Carlisle V, Krykant P, Maynard OM. Holland A, et al. Among authors: howkins j. Int J Drug Policy. 2024 Oct;132:104543. doi: 10.1016/j.drugpo.2024.104543. Epub 2024 Sep 3. Int J Drug Policy. 2024. PMID: 39226769 Free article. Review.
Escalating drug related deaths in the UK.
Rae M, Howkins J, Holland A. Rae M, et al. Among authors: howkins j. BMJ. 2022 Aug 16;378:o2005. doi: 10.1136/bmj.o2005. BMJ. 2022. PMID: 35973697 No abstract available.
Analysis of the UK Government's 10-Year Drugs Strategy-a resource for practitioners and policymakers.
Holland A, Stevens A, Harris M, Lewer D, Sumnall H, Stewart D, Gilvarry E, Wiseman A, Howkins J, McManus J, Shorter GW, Nicholls J, Scott J, Thomas K, Reid L, Day E, Horsley J, Measham F, Rae M, Fenton K, Hickman M. Holland A, et al. Among authors: howkins j. J Public Health (Oxf). 2023 Jun 14;45(2):e215-e224. doi: 10.1093/pubmed/fdac114. J Public Health (Oxf). 2023. PMID: 36309802 Free PMC article.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Correction to: Epilepsy related multimorbidity, polypharmacy and risks in adults with intellectual disabilities: a national study.
Sun JJ, Perera B, Henley W, Angus-Leppan H, Sawhney I, Watkins L, Purandare KN, Eyeoyibo M, Scheepers M, Lines G, Winterhalder R, Ashby S, De Silva R, Miller J, Philpott DE, Ashwin C, Howkins J, Slater H, Medhurst D, Shankar R. Sun JJ, et al. Among authors: howkins j. J Neurol. 2022 May;269(5):2761. doi: 10.1007/s00415-022-11012-2. J Neurol. 2022. PMID: 35247093 No abstract available.
37 results